Cargando…

Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype

BACKGROUND: Some COPD patients are more susceptible to exacerbations than others. Mechanisms underlying these differences in susceptibility are not well understood. We hypothesized that altered cell mediated immune responses may underlie a propensity to suffer from frequent exacerbations in COPD. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Geerdink, Jasper X., Simons, Sami O., Pike, Rebecca, Stauss, Hans J., Heijdra, Yvonne F., Hurst, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084432/
https://www.ncbi.nlm.nih.gov/pubmed/27793198
http://dx.doi.org/10.1186/s12931-016-0456-y
_version_ 1782463382361735168
author Geerdink, Jasper X.
Simons, Sami O.
Pike, Rebecca
Stauss, Hans J.
Heijdra, Yvonne F.
Hurst, John R.
author_facet Geerdink, Jasper X.
Simons, Sami O.
Pike, Rebecca
Stauss, Hans J.
Heijdra, Yvonne F.
Hurst, John R.
author_sort Geerdink, Jasper X.
collection PubMed
description BACKGROUND: Some COPD patients are more susceptible to exacerbations than others. Mechanisms underlying these differences in susceptibility are not well understood. We hypothesized that altered cell mediated immune responses may underlie a propensity to suffer from frequent exacerbations in COPD. METHODS: Peripheral blood mononuclear cells (PBMCs) were obtained from 24 stable COPD patients, eight frequent exacerbators (≥3 diary-card exacerbations/year) and 16 infrequent exacerbators (< 3 diary-card exacerbations/year). Detailed multi-parameter flow cytometry was used to study differences in innate and adaptive systemic immune function between frequent and infrequently exacerbating COPD patients. RESULTS: The 24 COPD patients had a mean (SD) age of 76.3 (9.4) years and FEV(1) 1.43 (0.60)L, 53.3 (18.3)% predicted. PBMCs of frequent exacerbators (FE) contained lower frequencies of CD4+ T central memory cells (CD4+ Tcm) compared to infrequent exacerbators (IE) (FE = 18.7 %; IE = 23.9 %; p = 0.035). This observation was also apparent in absolute numbers of CD4+ Tcm cells (FE = 0.17 × 10^6/mL; IE = 0.25 × 10^6/mL; p = 0.035). PBMCs of FE contained a lower frequency of CD8+ T effector memory cells expressing HLA-DR (Human Leukocyte Antigen - D Related) compared to IE COPD patients (FE = 22.7 %; IE = 31.5 %; p = 0.007). CONCLUSION: Differences in the adaptive systemic immune system might associate with exacerbation susceptibility in the ‘frequent exacerbator’ COPD phenotype. These differences include fewer CD4+ T central memory cells and CD8+ T effector memory cells. TRIAL REGISTRATION: Not applicable.
format Online
Article
Text
id pubmed-5084432
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50844322016-10-31 Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype Geerdink, Jasper X. Simons, Sami O. Pike, Rebecca Stauss, Hans J. Heijdra, Yvonne F. Hurst, John R. Respir Res Research BACKGROUND: Some COPD patients are more susceptible to exacerbations than others. Mechanisms underlying these differences in susceptibility are not well understood. We hypothesized that altered cell mediated immune responses may underlie a propensity to suffer from frequent exacerbations in COPD. METHODS: Peripheral blood mononuclear cells (PBMCs) were obtained from 24 stable COPD patients, eight frequent exacerbators (≥3 diary-card exacerbations/year) and 16 infrequent exacerbators (< 3 diary-card exacerbations/year). Detailed multi-parameter flow cytometry was used to study differences in innate and adaptive systemic immune function between frequent and infrequently exacerbating COPD patients. RESULTS: The 24 COPD patients had a mean (SD) age of 76.3 (9.4) years and FEV(1) 1.43 (0.60)L, 53.3 (18.3)% predicted. PBMCs of frequent exacerbators (FE) contained lower frequencies of CD4+ T central memory cells (CD4+ Tcm) compared to infrequent exacerbators (IE) (FE = 18.7 %; IE = 23.9 %; p = 0.035). This observation was also apparent in absolute numbers of CD4+ Tcm cells (FE = 0.17 × 10^6/mL; IE = 0.25 × 10^6/mL; p = 0.035). PBMCs of FE contained a lower frequency of CD8+ T effector memory cells expressing HLA-DR (Human Leukocyte Antigen - D Related) compared to IE COPD patients (FE = 22.7 %; IE = 31.5 %; p = 0.007). CONCLUSION: Differences in the adaptive systemic immune system might associate with exacerbation susceptibility in the ‘frequent exacerbator’ COPD phenotype. These differences include fewer CD4+ T central memory cells and CD8+ T effector memory cells. TRIAL REGISTRATION: Not applicable. BioMed Central 2016-10-28 2016 /pmc/articles/PMC5084432/ /pubmed/27793198 http://dx.doi.org/10.1186/s12931-016-0456-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Geerdink, Jasper X.
Simons, Sami O.
Pike, Rebecca
Stauss, Hans J.
Heijdra, Yvonne F.
Hurst, John R.
Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype
title Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype
title_full Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype
title_fullStr Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype
title_full_unstemmed Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype
title_short Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype
title_sort differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ copd phenotype
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084432/
https://www.ncbi.nlm.nih.gov/pubmed/27793198
http://dx.doi.org/10.1186/s12931-016-0456-y
work_keys_str_mv AT geerdinkjasperx differencesinsystemicadaptiveimmunitycontributetothefrequentexacerbatorcopdphenotype
AT simonssamio differencesinsystemicadaptiveimmunitycontributetothefrequentexacerbatorcopdphenotype
AT pikerebecca differencesinsystemicadaptiveimmunitycontributetothefrequentexacerbatorcopdphenotype
AT stausshansj differencesinsystemicadaptiveimmunitycontributetothefrequentexacerbatorcopdphenotype
AT heijdrayvonnef differencesinsystemicadaptiveimmunitycontributetothefrequentexacerbatorcopdphenotype
AT hurstjohnr differencesinsystemicadaptiveimmunitycontributetothefrequentexacerbatorcopdphenotype